BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20024905)

  • 1. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate.
    Lewis K; Lutgendorff F; Phan V; Söderholm JD; Sherman PM; McKay DM
    Inflamm Bowel Dis; 2010 Jul; 16(7):1138-48. PubMed ID: 20024905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.
    Nazli A; Wang A; Steen O; Prescott D; Lu J; Perdue MH; Söderholm JD; Sherman PM; McKay DM
    Infect Immun; 2006 Jan; 74(1):192-201. PubMed ID: 16368973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelia under metabolic stress perceive commensal bacteria as a threat.
    Nazli A; Yang PC; Jury J; Howe K; Watson JL; Söderholm JD; Sherman PM; Perdue MH; McKay DM
    Am J Pathol; 2004 Mar; 164(3):947-57. PubMed ID: 14982848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha.
    Lewis K; Caldwell J; Phan V; Prescott D; Nazli A; Wang A; Soderhölm JD; Perdue MH; Sherman PM; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G669-78. PubMed ID: 18187519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3'-kinase is a critical mediator of interferon-gamma-induced increases in enteric epithelial permeability.
    McKay DM; Watson JL; Wang A; Caldwell J; Prescott D; Ceponis PM; Di Leo V; Lu J
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1013-22. PubMed ID: 17178936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced intestinal epithelial mitochondrial function enhances in vitro interleukin-8 production in response to commensal Escherichia coli.
    Saxena A; Lopes F; McKay DM
    Inflamm Res; 2018 Oct; 67(10):829-837. PubMed ID: 30030553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate reduces adherent-invasive
    Hamed SA; Mohan A; Navaneetha Krishnan S; Wang A; Drikic M; Prince NL; Lewis IA; Shearer J; Keita ÅV; Söderholm JD; Shutt TE; McKay DM
    Gut Microbes; 2023 Dec; 15(2):2281011. PubMed ID: 38078655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C.
    Schoultz I; McKay CM; Graepel R; Phan VC; Wang A; Söderholm J; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G536-45. PubMed ID: 22700821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the NOD2 protein renders epithelia more susceptible to barrier dysfunction due to mitochondrial dysfunction.
    Saxena A; Lopes F; Poon KKH; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G26-G38. PubMed ID: 28450277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma signals via an ERK1/2-ARF6 pathway to promote bacterial internalization by gut epithelia.
    Smyth D; McKay CM; Gulbransen BD; Phan VC; Wang A; McKay DM
    Cell Microbiol; 2012 Aug; 14(8):1257-70. PubMed ID: 22463716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction.
    Lopes F; Keita ÅV; Saxena A; Reyes JL; Mancini NL; Al Rajabi A; Wang A; Baggio CH; Dicay M; van Dalen R; Ahn Y; Carneiro MBH; Peters NC; Rho JM; MacNaughton WK; Girardin SE; Jijon H; Philpott DJ; Söderholm JD; McKay DM
    J Biol Chem; 2018 Mar; 293(9):3073-3087. PubMed ID: 29317503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function.
    Zareie M; Riff J; Donato K; McKay DM; Perdue MH; Soderholm JD; Karmali M; Cohen MB; Hawkins J; Sherman PM
    Cell Microbiol; 2005 Dec; 7(12):1782-97. PubMed ID: 16309464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line.
    Inan MS; Rasoulpour RJ; Yin L; Hubbard AK; Rosenberg DW; Giardina C
    Gastroenterology; 2000 Apr; 118(4):724-34. PubMed ID: 10734024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury.
    Scheppach W; Dusel G; Kuhn T; Loges C; Karch H; Bartram HP; Richter F; Christl SU; Kasper H
    Gut; 1996 Jun; 38(6):878-85. PubMed ID: 8984027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.
    Russo I; Luciani A; De Cicco P; Troncone E; Ciacci C
    PLoS One; 2012; 7(3):e32841. PubMed ID: 22412931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate protects Caco-2 cells from Campylobacter jejuni invasion and translocation.
    Van Deun K; Pasmans F; Van Immerseel F; Ducatelle R; Haesebrouck F
    Br J Nutr; 2008 Sep; 100(3):480-4. PubMed ID: 18275629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process.
    Clark E; Hoare C; Tanianis-Hughes J; Carlson GL; Warhurst G
    Gastroenterology; 2005 May; 128(5):1258-67. PubMed ID: 15887109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's Disease Pathobiont Adherent-Invasive E coli Disrupts Epithelial Mitochondrial Networks With Implications for Gut Permeability.
    Mancini NL; Rajeev S; Jayme TS; Wang A; Keita ÅV; Workentine ML; Hamed S; Söderholm JD; Lopes F; Shutt TE; Shearer J; McKay DM
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):551-571. PubMed ID: 32992049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.
    Geirnaert A; Calatayud M; Grootaert C; Laukens D; Devriese S; Smagghe G; De Vos M; Boon N; Van de Wiele T
    Sci Rep; 2017 Sep; 7(1):11450. PubMed ID: 28904372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis.
    Wang A; Keita ÅV; Phan V; McKay CM; Schoultz I; Lee J; Murphy MP; Fernando M; Ronaghan N; Balce D; Yates R; Dicay M; Beck PL; MacNaughton WK; Söderholm JD; McKay DM
    Am J Pathol; 2014 Sep; 184(9):2516-27. PubMed ID: 25034594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.